V30 Stock Overview

Operates an online pharmacy in Sweden. More details

V30 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 45.3% below our estimate of its fair value

Earnings grew by 174.5% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Apotea AB (publ) Competitors

Hawesko Holding

XTRA:HAW

€229.1m

Ain Holdings

TSE:9627

JP¥150.3b

Anhui Huaren Health Pharmaceutical

SZSE:301408

CN¥4.9b

WASGAU Produktions & Handels

DB:MSH

€64.7m

Price History & Performance

Summary of share price highs, lows and changes for Apotea
Historical stock prices
Current Share Price	SEK 6.94
52 Week High	SEK 8.70
52 Week Low	SEK 6.79
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0.64%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	V30	DE Consumer Retailing	DE Market
7D	2.2%	-4.6%	-1.1%
1Y	n/a	-12.1%	8.1%

Return vs Industry: Insufficient data to determine how V30 performed against the German Consumer Retailing industry.

Return vs Market: Insufficient data to determine how V30 performed against the German Market.

Price Volatility

Is V30's price volatile compared to industry and market?
V30 volatility
V30 Average Weekly Movement	n/a
Consumer Retailing Industry Average Movement	6.0%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.8%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: V30's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine V30's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2011	767	Par Svardson	www.apotea.se

Apotea AB (publ) operates an online pharmacy in Sweden. It offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, dietary supplements, body care, stomach and intestine, food and beverage, mouth and teeth, toiletries, travel packaging and accessories, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, and eyes and ears. The company was founded in 2011 and is headquartered in Stockholm, Sweden.

Apotea AB (publ) Fundamentals Summary

How do Apotea's earnings and revenue compare to its market cap?
V30 fundamental statistics
Market cap	€737.08m
Earnings (TTM)	€16.75m
Revenue (TTM)	€548.86m

44.0x

P/E Ratio

1.3x

P/S Ratio

Is V30 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
V30 income statement (TTM)
Revenue	SEK 6.30b
Cost of Revenue	SEK 4.58b
Gross Profit	SEK 1.73b
Other Expenses	SEK 1.54b
Earnings	SEK 192.40m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.87
Gross Margin	27.40%
Net Profit Margin	3.05%
Debt/Equity Ratio	2.4%

How did V30 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 22:19
End of Day Share Price	2024/12/18 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Apotea AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution